Cargando…

Metabolic Risks Are Increasing in Non-B Non-C Early-Stage Hepatocellular Carcinoma: A 10-Year Follow-Up Study

BACKGROUND: Non-B, non-C hepatocellular carcinoma (NBNC-HCC) may be related to metabolic syndrome, and the incidence of this tumor type is increasing annually. The definition of metabolic-associated fatty liver disease (MAFLD) proposed in 2020 may help to more accuratelyassess the association betwee...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Yen-Po, Wang, Pei-Ming, Chuang, Ching-Hui, Yong, Chee-Chen, Liu, Yueh-Wei, Huang, Pao-Yuan, Yao, Chih-Chien, Tsai, Ming-Chao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848276/ https://www.ncbi.nlm.nih.gov/pubmed/35186751 http://dx.doi.org/10.3389/fonc.2022.816472

Ejemplares similares

Concurrent Cholecystectomy Is Associated with a Lower Risk of Recurrence after Curative Resection in Early-Stage Hepatocellular Carcinoma: A 10 Year Observational Single-Center Study
por: Chen, Yu-Syuan, et al.
Publicado: (2021)

The Impact of Direct-Acting Antiviral Therapy on the Risk of Recurrence after Curative Resection in Patients with Hepatitis-C-Virus-Related Early Stage Hepatocellular Carcinoma
por: Chen, Yu-Syuan, et al.
Publicado: (2022)

The Role of Protease-Activated Receptor 2 in Hepatocellular Carcinoma after Hepatectomy
por: Tsai, Ming-Chao, et al.
Publicado: (2021)

Role of non-coding RNAs in radiosensitivity of colorectal cancer: A narrative review
por: Huang, Chun-Ming, et al.
Publicado: (2022)

Clinical impact of albumin in advanced head and neck cancer patients with free flap reconstruction—a retrospective study
por: Tsai, Ming-Hsien, et al.
Publicado: (2018)

Clinical impact of human papillomavirus in laryngeal squamous cell carcinoma: a retrospective study
por: Chen, Wei-Chih, et al.
Publicado: (2017)

Impact of MAFLD on HBV-Related Stage 0/A Hepatocellular Carcinoma after Curative Resection
por: Lin, Yen-Po, et al.
Publicado: (2021)

Statin use is associated with a lower risk of recurrence after curative resection in BCLC stage 0-A hepatocellular carcinoma
por: Yang, Shih-Yu, et al.
Publicado: (2021)

Extensive-Stage Small Cell Carcinoma Transformation From EGFR Del19-Mutant Lung Adenocarcinoma on Gefitinib at the Twelfth-Year Follow-Up Case Report
por: Kok, Victor C., et al.
Publicado: (2021)

Preoperative ALBI grade predicts the outcomes in non-B non-C HCC patients undergoing primary curative resection
por: Tsai, Yu-Chieh, et al.
Publicado: (2021)

The Effectiveness and Safety of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer Patients With Stage III/IV: A Multicenter Study
por: Hsu, Jason C., et al.
Publicado: (2021)

Multidisciplinary Taiwan consensus for the use of conventional TACE in hepatocellular carcinoma treatment
por: Chang, Pi-Yi, et al.
Publicado: (2023)

Platelet Activation in High D-Dimer Plasma Plays a Role in Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Mutant Lung Adenocarcinoma
por: Lee, Meng-Jung, et al.
Publicado: (2022)

Circulating Tumor DNA as a Predictive Marker of Recurrence for Patients With Stage II-III Breast Cancer Treated With Neoadjuvant Therapy
por: Lin, Po-Han, et al.
Publicado: (2021)

Nivolumab Versus Regorafenib in Patients With Hepatocellular Carcinoma After Sorafenib Failure
por: Kuo, Yuan-Hung, et al.
Publicado: (2021)

Cost-effectiveness analysis of atezolizumab plus bevacizumab versus sorafenib in first line treatment for Chinese subpopulation with unresectable hepatocellular carcinoma
por: Tseng, Chien-Yu, et al.
Publicado: (2023)

The combination of sarcopenia and biochemical factors can predict the survival of hepatocellular carcinoma patients receiving transarterial chemoembolization
por: Chien, Tzu-Ping, et al.
Publicado: (2022)

Comparison of 10 noninvasive models for predicting overall survival in patients with intermediate-stage hepatocellular carcinoma
por: Hsu, Wei-Fan, et al.
Publicado: (2021)

Combined Impacts of Genetic Variants of Long Non-Coding RNA MALAT1 and the Environmental Carcinogen on the Susceptibility to and Progression of Oral Squamous Cell Carcinoma
por: Ding, Yi-Fang, et al.
Publicado: (2021)

Impact of metformin use on the recurrence of hepatocellular carcinoma after initial liver resection in diabetic patients
por: Cho, Wei-Ru, et al.
Publicado: (2021)

Pinostilbene Hydrate Inhibits the Migration and Invasion of Human Nasopharyngeal Carcinoma Cells by Downregulating MMP-2 Expression and Suppressing Epithelial–Mesenchymal Transition Through the Mitogen-Activated Protein Kinase Signaling Pathways
por: Tseng, Pao-Yu, et al.
Publicado: (2019)

Real-World Lenvatinib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis
por: Kuo, Yuan-Hung, et al.
Publicado: (2021)

Corrigendum: Real-World Lenvatinib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis
por: Kuo, Yuan-Hung, et al.
Publicado: (2021)

Circulating Let-7 Family Members as Non-Invasive Biomarkers for Predicting Hepatocellular Carcinoma Risk after Antiviral Treatment among Chronic Hepatitis C Patients
por: Tsai, Yi-Shan, et al.
Publicado: (2022)

Pre- and Postoperative Models for Prediction of Recurrence in Non-B, Non-C Hepatocellular Carcinoma
por: Lin, Kongying, et al.
Publicado: (2021)

Role of FDG-PET scans in staging, response assessment, and follow-up care for non-small cell lung cancer
por: Cuaron, John, et al.
Publicado: (2013)

Living donor liver transplantation for Barcelona clinic liver cancer (BCLC) intermediate-stage hepatocellular carcinoma
por: Tsai, Ming Chao, et al.
Publicado: (2022)

Body composition as a predictor of oncological outcome in patients with non-muscle-invasive bladder cancer receiving intravesical instillation after transurethral resection of bladder tumor
por: Huang, Liang-Kang, et al.
Publicado: (2023)

Oncological Outcomes of Robotic-Assisted Surgery With High Dissection and Selective Ligation Technique for Sigmoid Colon and Rectal Cancer
por: Yin, Tzu-Chieh, et al.
Publicado: (2020)

Prognostic stratification of patients with AJCC 2018 pN1 disease in stage III oral squamous cell carcinoma
por: Tsai, Ming-Hsien, et al.
Publicado: (2022)

Inhibition of FAK Signaling Elicits Lamin A/C-Associated Nuclear Deformity and Cellular Senescence
por: Chuang, Hsiang-Hao, et al.
Publicado: (2019)

Ability of the post-operative ALBI grade to predict the outcomes of hepatocellular carcinoma after curative surgery
por: Cho, Wei-Ru, et al.
Publicado: (2020)

Comparison of stereotactic body radiation therapy with hepatic resection and radiofrequency ablation as initial treatment in patients with early-stage hepatocellular carcinoma
por: Yang, Zi-liang, et al.
Publicado: (2022)

The Role of Non-Coding RNAs in the Sorafenib Resistance of Hepatocellular Carcinoma
por: Hu, Xinyao, et al.
Publicado: (2021)

The Impact of Long Non-Coding RNAs in the Pathogenesis of Hepatocellular Carcinoma
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2021)

The Potential Roles of Exosomal Non-Coding RNAs in Hepatocellular Carcinoma
por: Wang, Wei, et al.
Publicado: (2022)

Efficacy of concurrent radiotherapy in patients with locally advanced rectal cancer and synchronous metastasis receiving systemic therapy
por: Yin, Tzu-Chieh, et al.
Publicado: (2023)

Adjuvant Sorafenib Following Radiofrequency Ablation for Early-Stage Recurrent Hepatocellular Carcinoma With Microvascular Invasion at the Initial Hepatectomy
por: Wei, Meng-Chao, et al.
Publicado: (2022)

Survival After Treatable Hepatocellular Carcinoma Recurrence in Liver Recipients: A Nationwide Cohort Analysis
por: Ho, Cheng-Maw, et al.
Publicado: (2021)

Significant down-regulation of growth hormone receptor expression revealed as a new unfavorable prognostic factor in hepatitis C virus-related hepatocellular carcinoma
por: Lin, Ching-Chih, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e2nam2m099j8dlhn7ucs51sauu